PRECISION CONTROL OF LARGE-SCALE GREEN SYNTHESIS OF BIODEGRADABLE GOLD NANODANDELIONS AS POTENTIAL RADIOTHERANOSTICS
20210387258 · 2021-12-16
Inventors
Cpc classification
B82Y5/00
PERFORMING OPERATIONS; TRANSPORTING
B22F9/24
PERFORMING OPERATIONS; TRANSPORTING
B82Y30/00
PERFORMING OPERATIONS; TRANSPORTING
B82Y40/00
PERFORMING OPERATIONS; TRANSPORTING
A61K41/0038
HUMAN NECESSITIES
International classification
B22F9/24
PERFORMING OPERATIONS; TRANSPORTING
A61K41/00
HUMAN NECESSITIES
Abstract
The present invention relates to a new type of metabolizable flower-like gold nanodandelion (GND), which possesses features: (1) large scale green synthesis with high monodispersity and a circa 100% yield; (2) cellular/physiological degradability; (3) precision control of the shape, petal number and size; (4) highly efficient radiotheranostics encompassing better enhanced CT contrast and pronounced x-ray induced ROS generation than conventional spherical AuNP.
Claims
1. A method for fabricating a gold nanoparticle which comprising the steps of: adding a gold seed suspension and an auric acid solution to a gelatin solution to form a mixture; incubating the mixture for a incubation period; and adding a reductant to the mixture;
2. The method according to claim 1, wherein the gelatin solution comprising type A gelatin.
3. The method according to claim 1, wherein the ratio of auric acid solution and gelatin solution ([auric acid](μM)/[Gelatin](mg mL.sup.−1)) is between 25 and 50.
4. The method according to claim 1, wherein the auric acid is chloroauric acid (HAuCl.sub.4).
5. The method according to claim 1, wherein the gold ion concentration of gold seed suspension is between 12.5 and 100 μM.
6. The method according to claim 1, wherein the incubation period is between 5 and 30 minutes.
7. The method according to claim 1, wherein the reductant is ascorbic acid.
8. The method according to claim 7, wherein the concentration of ascorbic acid is between 250 and 1000 μM.
9. A method for imaging of a subject, which comprising: administering to the subject an effective amount of the gold nanoparticle of claim 1; and irradiating the subject with a penetrating radiation.
10. The method according to claim 9, wherein the penetrating radiation is an X-ray.
11. A method for enhancing radiosensitivity of a cell population, which comprising: administering to the cell population an effective amount of the gold nanoparticle of claim 1; and irradiating the cell population with an X-ray.
12. The method according to claim 11, wherein the X-ray induces generation of reactive oxygen species (ROS).
13. A method for treating a cancer in a subject comprising: administering to the subject an effective amount of the gold nanoparticle of claim 1; and irradiating the subject with an X-ray.
14. The method according to claim 13, wherein the cancer is a glioma.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
DETAILED DESCRIPTION OF THE INVENTION
[0039] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by a person skilled in the art to which this invention belongs.
[0040] As used herein, the term “theranostics” refers to the systematic integration of targeted diagnostics and therapeutics. The theranostics platform includes an imaging component that “sees” the lesions followed by administration of the companion therapy agent that “treats” the same lesions.
[0041] As used herein, the term “radio-theranostics” refers to the therapy using ionizing radiation in the theranostic domain.
[0042] As used herein, the term “reactive oxygen species (ROS)” refers to the chemically reactive chemical species containing oxygen. Examples include peroxides, superoxide, hydroxyl radical, and singlet oxygen. ROS can damage lipid, DNA, RNA, and proteins, thus induce cell apoptosis.
[0043] As used herein, the term “biodegradable” refers to the environmentally friendly products that are biocompatibility, identified degradation mechanism and set of metabolic pathways.
[0044] The general protocol used to synthesize the GNDs is based on the reduction of HAuCl.sub.4 by AA and gelatin that act as a reductant and stabilizing agent, respectively.
[0045] As illustrated in
[0046] Upon reduction of AuCl.sub.4.sup.− by AA, primary Au.sup.0 are obtained from complex. Subsequently, AuNP seeds act as the centers to capture free gelatin-Au-complex, leading to the formation of anisotropic multi-branched structures.
[0047] With the increase of reaction times, free gelatin-Au-complex diffuses continually toward the hierarchy and deposits further on the empty surface, finally forms thicker petals and roughened surfaces.
[0048] The transmission electron microscopy (TEM) images and dynamic light scattering (DLS) measurement reveal that the flower-like morphology of GNDs exhibits a uniform size. The yield of the GNDs is approximately 100% of the particles have numerous petals, where no other shapes are found in any of the analyzed samples.
[0049] Hydrogen tetrachloroaurate (III) trihydrate (HAuCl.sub.4), trisodium citrate (Na.sub.3C.sub.6H.sub.5O.sub.7), L-ascorbic acid (C.sub.6H.sub.8O.sub.6), type A gelatin, dihyclroethidium (DHE), coumarin-3-carboxylic acid (3-CCA) and 1,3-Diphenylisobenzofuran (DPBF) are purchased from Sigma-Aldrich. All chemicals are used as received without further purification.
[0050] α-phospho-H2AX (Millipore, USA) (Dilution—1:1000) and dye conjugated goat anti-mouse Cy 5.5 (GeneTex, USA) are used as secondary antibody. MES-SA (human uterine sarcoma) and U87-MG (human glioblastoma) cell lines are purchased from American Tissue Culture Collection (ATCC). MES-SA and U87-MG cells are cultured using completed McCoy's 5A (Gibco) and DMEM (Clibco), respectively, with the addition of 10% and 1% penicillin-streptomycin antibiotic as per standard. This cell line is incubated at 37° C. in a fully humidified atmosphere of 5% CO.sub.2.
EXAMPLE 1: Synthesis of Gold Seed
[0051] Au seed nanoparticles are prepared as following: 3 mL of 38.8 mM of sodium citrate is added to 50 mL of a 1 mM HAuCl.sub.4 solution, and the mixture is heated by microwave; After 90 s, the mixture acquires a red-purple color, and then the solution is stored at 4° C.; A transmission electron microscopy (TEM) examination shows that the resulting AuNPs are spherical in shape with an average diameter of 20 nm.
EXAMPLE 2: Synthesis of Gold Nanodandelions
[0052] CiNDs are obtained through a seed-mediated route. In short, 4 mL of gelatin solution (10 mg.Math.mL.sup.−1) is kept at room temperature with gentle stirring. Then, 200 μL of citrate capped gold seeds and 8 μL of 250 mM HAuCl.sub.4 are added, and this mixture is aged for 10 min. The growth of GNDs occurs by adding 100 μL of 10 mM ascorbic acid aqueous solution, and stirring is immediately stopped. At the end of the reaction, the solution acquires a purple-blue color. Finally, the GNDs are purified by centrifugation and dispersed in PBS before use (so called gelatin-PEG). For PEG-GNDs synthesis, 10 μL, of 50 mM HS-PEG.sub.2000 is added to the GNDs and kept stirring for 2 h, Finally, the PEG-GNDs are purified by centrifugation and dispersed in PBS before use.
[0053] A representative transmission electron microscopy (TEM) image in
EXAMPLE 3: The Influence of the Incubation Time
[0054] The abovementioned diagram shows that electrostatic attraction between gelatin and AuCl.sub.4.sup.− ions influence the formation of the gelatin-Cl—Au—Cl.sub.2.sup.− complex. In addition, the interaction between gold seed and the amine group of gelatin control the fabrication of nanostructure. To prove this supposition, a series of control experiments, in which the ratio of [HAuCl.sub.4]/[gelatin] is fixed, and mediated the incubation time. The irregular gold nanostructure is observed as reductant is added immediately into the reaction solution (
[0055] Furthermore, when the incubation time is between 10 and 30 min, the multi-petals GNDs are developed (
EXAMPLE 4: The Influence of the Concentration of HAuCl.SUB.4
[0056] As mentioned above, the attraction between AuCl.sub.4.sup.- ions and gelatin could control the growth and preferential directionality of petals. Hence, the influence of [HAuCl.sub.4 (μM)]/[gelatin (mg ml.sup.−)] is explored by mediating the concentration of HAuCl.sub.4 while keeping the gelatin concentration fixed. The ratio of HAuCl.sub.4 to gelatin plays an important role in the formation of uniform flower-like GNDs. Only spherical AuNPs are obtained in the lowest ratio, 12.5 (
Example 5: The Influence of the Ratio of [HAuCl.SUB.4.]/[Gelatin]
[0057] To prove the ratio of [HAuCl.sub.4]/[gelatin] is the determining factor for varied morphology but not the concentration of gelatin or HAuCl.sub.4, as a control experiment, GNDs with varying concentrations of HAuCl.sub.4 and gelatin with their ratios fixed are synthesized GNDs.sub.500:10, GNDs.sub.250:5, and GNDs.sub.50:1. From the TEM observations, the size of GNDs.sub.50:1 is slightly smaller than GNDs.sub.250:5 and GNDs.sub.500:10 and the synthesized NPs are mainly multi-petals (see
EXAMPLE 6: The Influence of the Concentration of Ascorbic Acid and Gold Seed
[0058] Represented in
[0059] The influence of the seed concentration (concentration of gold ion) on the properties of the as-prepared GNDs is studied in this section. As the amount of seeds increases from 0 to 50 μM, the as-prepared NPs retain a multi-branched structure, but a clear decrease in the diameters is observed (
EXAMPLE 6: The Internalization and Degradation of Gold Nanodandelions
[0060] It is commonly believed that internalized nanoparticles deliver a highly inhoinogeneous distribution of energy on the sub-cellular scale upon X-ray irradiation, thus leading to a larger extent of DNA damage, meaning that cellular distribution of nanoparticles will have a direct influence on the degree of radio-sensitization. For this reason, the internalization of GNDs is first investigated. To measure the amount of gold nanomaterials expelled by cells, three-dimensional tumor spheroids are used in this study, Brief, U87-MG cells are seeded into 2% agarose precoated 24-well plates at a density of 1×10.sup.4 cells/well. Five days later, the spheroids are exposed to 4 μg mL.sup.−1 either GNDs or AuNPs. After 24 h incubation, spheroids are rinsed with ice-cold PBS twice and the medium was replaced with fresh medium without gold nanomateirals. To eliminate the extracellular gold nanomaterials, the medium is removed every day and the spheroids were collected at 0, 3, 10, and 17 day. The experiments are conducted in triplicate. The mass of gold determined from the ICP-MS is reported in ppb of gold per sample.
[0061] Their cell uptake is observed after 24 h incubation with either GNDs or spherical AuNPs in the cell culture medium. As show in
[0062] One interesting observation from the TEM images depicts that GNDs appear monodispersed and some gold debris are found (
EXAMPLE 7: The Potential of GNDs as a CT Contrast Agent and Radio-Sensitizer in Comparison to Spherical AuNPs
[0063] As seen in the inset of
[0064] In addition to CT contrast enhancements, the radio-sensitization properties are investigated by examining the ROS production. For the quantification of ROS, three specific species, .OH, O.sub.2..sup.−, and singlet oxygen (.sup.1O.sub.2), are chosen for their biological importance. The generation of these species is measured by three kinds of probes, DPBF (absorbance: 414 nm), DHE (emission: 585 nm), and 3-CCA (emission: 450 nm) dedicate to the quantification of integrated amounts of .sup.1O.sub.2, O.sub.2. .sup.− and .OH, respectively. GNDs are suspended with 500 μL PBS for ROS measurement. A ROS probe is premixed with GNDs and then diluted by PBS for the designed final concentration. The resulting final concentrations of DPBF, DHE and 3-CCA are 30, 25, and 50 μM, respectively. Solutions are then exposed to X-rays using a commercial cabinet X-ray system with the standard X-ray tube operated at 160 kV and 25 mA. Singlet oxygen measurements are made by following the loss of fluorescence intensity of DBPF in the aqueous GNDs solutions. In DHE measurements, the solution is excited at 465 nm and its fluorescence intensity is measured for super oxide generation. In the 3-CCA measurement, hydroxyl radical is measured by following the increase of fluorescence intensity.
[0065] For the singlet oxygen detection,
[0066] Other biologically important ROS, such as .OH and O.sub.2..sup.−,
[0067] The intensities in
EXAMPLE 8: Concentration-Dependent in vitro Toxicity of GNOs
[0068] For biomedical applications, it is essential to evaluate the cytotoxicity of our established GNDs. To determine the cytotoxicity, cell viability is determined by MTT assay and YOPRO-1/PI staining kit. It is clearly evident from
[0069] EXAMPLE 9: Cell CT-imaging of MMP-responsive GNDs
[0070] To further study CT-imaging ability of MMP-responsive GNDs, U87 MG cells are allowed to co-incubate with either gelatin-GNDs or PEG-GNDs.
EXAMPLE 10: Irreversible DNA Damage Induced by the Synergistic Effects of GNDs and X-Ray Radiation
[0071] To further evaluate the radio-sensitization effect of GNDs in vitro, radio-resistant glioma cell, U87-MG, is irradiated (5 Gy) and observed double-stranded DNA damage via γ-H2AX staining to confirm the synergistic DNA damage induced by the synergistic effects of GNDs and X-ray radiation, Phosphorylated histone H2AX is widely regarded as a molecular marker for DNA double-stranded break. Briefly, after different treatment for 24 h, cells are washed twice with PBS, fixed with 4% glutaraldehyde for 10 min, and permeabilized with 0.5 % Triton X-100. Next, cells are blocked in 5% bovine serum albumin for 1 h, and subsequently incubated overnight at 4° C. with monoclonal antihuman phospho-H2AX (S139) mouse mAb (Millipore, USA) at 1:1000 dilution in PBS (with 0.1% Triton X-100 and 5% BSA). Cells are washed with PBS and then incubated with goat anti-mouse Cy5.5 secondary antibody (GeneTex) at 1:1000 dilution in PBS (with 0.1′/i) Triton X-100 and 5% BSA) for 1 h at room temperature. Nuclei are stained blue with Hoechst 33342.
[0072] As shown in
EXAMPLE 11: The Dysfunctional Mitosis Induced by the Synergistic Effects of GNDs and X-Ray Radiation
[0073] To further confirm these results, we also analyse changes in nucleus morphology following X-ray irradiation. As shown in
EXAMPLE 12: Enhanced GND Intracellular Accumulation of MMP Overexpressed Cancer Cells
[0074] In order to enhance the therapeutic outcome and minimize side effects to the normal tissues, nanocarriers that respond to tumor microenvironment stimuli such as pH, redox potential, and enzymes are of particular interest. Several studies about tumor development and metastasis found that matrix metalloproteases On/PO are ubiquitously overexpressed and actively involved in tumor development. Therefore, MMPs are widely used as an attractive tumor specific stimuli in targeted drug delivery. In this study, gelatin, a substrate of MMP-2/MMP-9 is used as a biodirecting agent to synthesize GNDs. Therefore, our established GNDs (so-called gelatin-GNDs) is MMP-responsive for enhance intracellular accumulation. To confirm the enhanced intracellular accumulation, MMP-2 and -9 overexpressed cancer cells such as C6, U87 MG, Hela and MDA-MB 231 are selected for zymography assay (
[0075] EXAMPLE 13: Radiosensitizing Effects of Gelatin-GNDs in C6 Tumor Bearing Nude Mice
[0076] To determine the efficacy of gelatin-GNDs on radiosensitization using, clonogenic cell survival assay is performed. As shown in
[0077] In summary, a facile and environmentally friendly strategy that uses gelatin as a biodirecting agent is presented for high-yield synthesis of highly monodisperse GNDs. The present invention provides great advantage over other methods in terms of low cost, green synthesis, and mass production. The morphology, size and number of petals of GNDs can be changed by altering the ratio of [HAuCl.sub.4]/[gelatin], seed concentration, and reductant concentration, respectively. Some embodiments that involved ROS production reveals that the CT contrast enhancing GNDs also pronounce more ROS generation than conventional AuNPs that enables its application as second-generation radiosensitizer for potential clinical theranostics. Subsequently, GNDs undergo self-degradation to smaller sized debris, which is desirable for effective clearance from the body. Overall, all of these benefits promise a new efficient theranostic modality for in vivo animal and clinical uses.